Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inter-Laboratory Proficiency Testing Scheme for Tumour Next-Generation Sequencing in Ontario: A Pilot Study

1 Dec 2019

Abstract excerpt

Background: A pilot inter-laboratory proficiency scheme for 5 Ontario clinical laboratories testing tumour samples for the Ontario-wide Cancer Targeted Nucleic Acid Evaluation (octane) study was undertaken to assess proficiency in the identification and reporting of next-generation sequencing (ngs) test results in solid tumour testing from archival formalin-fixed, paraffin-embedded (ffpe) tissue. Methods: One...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Genetic factors in colorectal cancer
Share to Genomics and Rare Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31896942
DOI: 10.3747/co.26.5379

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Inter-Laboratory Proficiency Testing Scheme for Tumour Next-Generation Sequencing in Ontario: A Pilot StudyPMID 31896942Read ↗

OCTANE (Ontario-Wide Cancer Targeted Nucleic Acid Evaluation): A Platform for Intraprovincial, National, and International Clinical Data-SharingSemantic proximity Read ↗

Implementation of an ISO 15189 accredited next generation sequencing service for cell-free total nucleic acid (cfTNA) analysis to facilitate driver mutation reporting in blood: the experience of a clinical diagnostic laboratorySemantic proximity Read ↗

Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.Semantic proximity Read ↗

Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer.Semantic proximity Read ↗

Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing–Based Oncology AssaysSemantic proximity Read ↗

Implementation of an ISO15189 accredited next-generation sequencing service with the fully automated Ion Torrent Genexus: the experience of a clinical diagnostic laboratory.Semantic proximity Read ↗

Tutorial for variant interrogation in tumor samples.Semantic proximity Read ↗

Results of the UK NEQAS for Molecular Genetics reference sample analysis.Semantic proximity Read ↗

Clinical validation of the 50 gene AmpliSeq Cancer Panel V2 for use on a next generation sequencing platform using formalin fixed, paraffin embedded and fine needle aspiration tumour specimens.Semantic proximity Read ↗

Ultra-deep sequencing data from a liquid biopsy proficiency study demonstrating analytic validity.Semantic proximity Read ↗

Standard operating procedure for somatic variant refinement of sequencing data with paired tumor and normal samples.Semantic proximity Read ↗

Implementing NGS-based BRCA tumour tissue testing in FFPE ovarian carcinoma specimens: hints from a real-life experience within the framework of expert recommendationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.